EFFECTS OF HTD1801 (BERBERINE URSODEOXYCHOLATE) IN SUBJECTS WITH PRIMARY SCLEROSING CHOLANGITIS PREVIOUSLY EXPOSED TO UDCA

被引：0
|
作者：
Kowdley, Kris V. [1 ,2 ]
Forman, Lisa [3 ]
MacConell, Leigh [4 ]
Hirschfield, Gideon [5 ]
机构：
[1] Liver Inst Northwest, Seattle, WA USA
[2] Washington State Univ, Elson S Floyd Coll Med, Pullman, WA 99164 USA
[3] Univ Colorado, Boulder, CO 80309 USA
[4] Hightide Therapeut, Shenzhen, Peoples R China
[5] Univ Toronto, Toronto Ctr Liver Dis, Toronto, ON, Canada
来源：
HEPATOLOGY | 2021年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1267
引用
收藏
页码：760A / 761A
页数：2
相关论文
共 24 条
  • [21] A Randomized, Dose-Finding, Proof-of-Concept Study of Berberine Ursodeoxycholate in Patients With Primary Sclerosing Cholangitis
    Kowdley, Kris V.
    Forman, Lisa
    Eksteen, Bertus
    Gunn, Nadege
    Sundaram, Vinay
    Landis, Charles
    Harrison, Stephen A.
    Levy, Cynthia
    Liberman, Alexander
    Di Bisceglie, Adrian M.
    Hirschfield, Gideon M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (11): : 1805 - 1815
  • [22] Improvements in liver fibroinflammation (as assessed by corrected T1 [cT1]) with HTD1801 (berberine ursodeoxycholate) treatment in patients with non-alcoholic steatohepatitis and type 2 diabetes mellitus
    Harrison, Stephen
    Gunn, Nadege
    Neff, Guy
    Flyer, Abbey
    Liberman, Alexander
    MacConell, Leigh
    JOURNAL OF HEPATOLOGY, 2023, 78 : S653 - S654
  • [23] ANTRO-DUODENAL AND GALLBLADDER (GB) MOTILITY IN PRIMARY SCLEROSING CHOLANGITIS (PSC) - EFFECTS OF URSODEOXYCHOLIC ACID (UDCA)
    VANDEMEEBERG, PC
    VANERPECUM, KJ
    SAMSOM, M
    STOLK, MFJ
    PORTINCASA, P
    AKKERMANS, LMA
    SMOUT, AJPM
    VANBERGEHENEGOUWEN, GP
    GASTROENTEROLOGY, 1994, 106 (04) : A1001 - A1001
  • [24] A network meta-analysis of the efficacy and side effects of udca-based therapies for primary sclerosing cholangitis
    Zhu, Gui-Qi
    Shi, Ke-Qing
    Huang, Gui-Qian
    Wang, Li-Ren
    Lin, Yi-Qian
    Braddock, Martin
    Chen, Yong-Ping
    Zhou, Meng-Tao
    Zheng, Ming-Hua
    ONCOTARGET, 2015, 6 (29) : 26757 - 26769
123